Global High Value Plant Compound Market Research Report Information by Source, Type, Application, Forecast Till 2032

Description

List of Tables

Global High Value Plant Compound Market Research Report Information by Source (Leaves, Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, Other Sources), Type (Phenylpropanoids, Alkaloids, Terpenoids, Polyketides), Application (Pharmaceuticals, Cosmetics, Food & Beverages, Dietary Supplements, Others, Forecast Till 2032

Market Overview

In 2023, the High Value Plant Compound Market Size was estimated to be USD 16,536.70 million. The Global High Value Plant Compound industry is anticipated to experience a compound annual growth rate (CAGR) of 11.69% from 2024 to 2032, resulting in a total value of USD 44,724.70 million.

The demand for plant-based supplements and nutraceuticals is being driven by the global health and wellness trend. Dietary supplements that promote overall health and address health issues are prepared using high-quality plant compounds. The demand for natural and organic products in a variety of industries, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages, is the primary driver of the global high-value plant compounds market. The market has experienced growth as a result of the increasing consumer awareness of the health benefits of these compounds and the increasing preference for natural products over synthetic ones. Nevertheless, the market is confronted with a variety of obstacles, including the high cost of extraction processes, regulatory obstacles, and concerns regarding the sustainable procurement of plant materials. It is anticipated that market participants will experience lucrative opportunities as a result of technological advancements in extraction techniques and a focus on research and development activities.

Market segment insights

Table 1 illustrates a substantial upward trajectory in the global market for high-value plant compounds from 2022 to 2032. The market, which was valued at USD 14,919.4 million in 2022, is expected to experience a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2032, culminating in a spectacular USD 44,724.7 million in 2032. These compounds, which are derived from a variety of plant sources, are of significant value because they are used in industries such as pharmaceuticals, cosmetics, and food.

Leaves comprise the greatest portion of this market among the various plant sources. Leaves generated USD 4,730.6 million in 2022, and this sector is anticipated to expand at a compound annual growth rate (CAGR) of 11.8%. The substantial increase in the leaves category can be attributed to the growing demand for herbal and botanical constituents in healthcare and wellness products. Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, and Other Sources are also significant contributors to this market, with CAGRs of 12.2%, 10.7%, 12.0%, and 11.5%, respectively.

One of the fastest-growing segments in the market is phenylpropanoids, including curcumin and resveratrol, with a compound annual growth rate (CAGR) of 11.7%. The antioxidant and anti-inflammatory properties of these compounds have made them a popular ingredient in dietary supplements and cosmetic products. Alkaloids and terpenoids are also positioned for significant growth, with anticipated compound annual growth rates (CAGRs) of 11.8% and 11.6%, respectively.

Regional Perspectives

In 2022, North America was the greatest market, with a market valuation of $4.3 billion. between 2022 and 2032, the region experienced substantial growth, with a Compound Annual Growth Rate (CAGR) of 11.21%. The burgeoning interest in natural remedies, dietary supplements, and wellness products is the primary factor driving the expansion of the high-value plant compounds market in North America.

Europe, which had a market value of $3.4 billion in 2022, exhibited a compound annual growth rate (CAGR) of 10.74% during the same period, indicating consistent growth. The market has expanded because of the adoption of high-value plant compounds by European consumers, particularly in cosmetics and dietary supplements.

The market value of $6.7 billion in 2022 was achieved by the Asia-Pacific region, which exhibited the maximum CAGR at 12.02% during the same period. The region's robust CAGR can be attributed to the extensive adoption of herbal and Ayurvedic remedies in the pharmaceutical and food industries, as well as the increasing popularity of these remedies in countries such as India and China.

Major Players

Merck KGaA, MedChemExpress, Selleck Chemicals, Biosynth, Tokyo Chemical Industry, Advion, Inc, Alkaloids Corporation, C-Squared Pharma S.a R.L., Linnea SA, and Inga Pharmaceuticals are among the key companies in the High Value Plant Compound market.

Product Code: MRFR/F-B & N/29704-CR

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS
- 1.1.1 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY SOURCES
- 1.1.2 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY TYPES
- 1.1.3 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY APPLICATION
- 1.1.4 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY REGION

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 MARKET STRUCTURE
2.4 KEY IMPLEMENTATION CRITERIA

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING DEMAND FOR NATURAL INGREDIENTS
- 4.2.2 GROWING COSMETICS AND PERSONAL CARE INDUSTRY
- 4.2.3 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF RESEARCH AND DEVELOPMENT
- 4.3.2 REGULATORY HURDLES AND COMPLIANCE ISSUES
- 4.3.3 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
- 4.4.1 TECHNOLOGICAL ADVANCEMENTS
4.5 CHALLENGES
- 4.5.1 CONSUMER AWARENESS AND ACCEPTANCE
- 4.5.2 TECHNOLOGICAL LIMITATIONS
4.6 IMPACT OF COVID-19 ON GLOBAL ECONOMY
4.7 IMPACT OF COVID-19 ON THE GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET
4.8 SUPPLY CHAIN IMPACT
- 4.8.1 IMPACT ON PRODUCTION
- 4.8.2 IMPACT ON RAW MATERIAL AVAILABILITY
- 4.8.3 IMPACT ON SUPPLY CHAIN
- 4.8.4 IMPACT ON APPLICATION AREAS

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY/VALUE CHAIN ANALYSIS
- 5.1.1 RAW MATERIALS SUPPLIERS
- 5.1.2 PRODUCTION/EXTRACTION
- 5.1.3 PACKING/ DISTRIBUTION
- 5.1.4 END-USERS
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 BARGAINING POWER OF BUYERS
- 5.2.4 THREAT OF SUBSTITUTES
- 5.2.5 INTENSITY OF RIVALRY

6 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY SOURCE

6.1 INTRODUCTION
6.2 LEAVES
6.3 RHIZOMES & ROOTS
6.4 BARKS & STEMS
6.5 FRUITS, FLOWERS, & BULBS
6.6 OTHER SOURCES (ALGAE, BACTERIA, SEA WEEDS)

7 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY TYPES

7.1 INTRODUCTION
7.2 PHENYLPROPANOIDS
7.3 ALKALOIDS
7.4 TERPENOIDS
7.5 POLYKETIDES

8 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY APPLICATIONS

8.1 INTRODUCTION
8.2 PHARMACEUTICALS
8.3 COSMETICS
8.4 FOOD AND BEVERAGES
8.5 DIETARY SUPPLEMENTS
8.6 OTHER APPLICATIONS

9 GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 U.S.
- 9.2.2 CANADA
- 9.2.3 MEXICO
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 U.K.
- 9.3.3 FRANCE
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 RUSSIA
- 9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 AUSTRALIA AND NEW ZEALAND
- 9.4.5 REST OF ASIA PACIFIC
9.5 MEA (MIDDLE EAST AND AFRICA)
- 9.5.1 GCC
- 9.5.2 SOUTH AFRICA
- 9.5.3 ROMEA
9.6 LATIN AMERICA
- 9.6.1 BRAZIL
- 9.6.2 ARGENTINA
- 9.6.3 ROLA (REST OF LATIN AMERICA)

10 COMPETITIVE LANDSCAPE

10.1 COMPETITIVE OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR PLAYERS IN THE GLOBAL HIGH VALUE PLANT COMPOUNDS MARKET

11 COMPANY PROFILES

11.1 ADVION, INC.
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 MERCK KGAA
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 BIOSYNTH
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 SELLECK CHEMICALS
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS/SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 MEDCHEMEXPRESS
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS/SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 ALKALOIDS CORPORATION
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS/SERVICES OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 C-SQUARED PHARMA S.A R.L.
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS/SERVICES OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 LINNEA SA
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS/SERVICES OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 INGA PHARMACEUTICALS
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 TOKYO CHEMICAL INDUSTRY
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 SWOT ANALYSIS
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES